NCT03835052View on ClinicalTrials.gov

QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care

TerminatedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

March 25, 2020

Study Completion Date

March 30, 2020

Conditions
Cancer
Trial Locations (1)

17822

Geisinger Medical Center, Danville

Sponsors

Lead Sponsor

Geisinger Clinic
All Listed Sponsors
lead

Geisinger Clinic

OTHER

NCT03835052 - QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care | Biotech Hunter | Biotech Hunter